Swiss stock market performance

The Swiss stock market has experienced recent volatility and slight declines. On October 26, the Swiss Leader Index (SLI) opened lower by 0.067 percent to 2,335.43 points, though it maintained a year-to-date increase of 8.56 percent. During that session, Novartis and VAT showed strength, while Schindler, Sika, and Nestlé faced downward pressure.

By October 28, the Swiss Market Index (SMI) closed down 0.11 percent at 14,581.10 points as investors exercised caution ahead of Federal Reserve interest rate decisions and European Central Bank commentary. Logitech saw a significant decline of 10.8 percent following its quarterly results and outlook. While companies like Sandoz, Geberit, Lonza, and Swiss Re declined, ABB, Partners Group, and Swiss Life recorded gains.

However, the SMI later reached a new record high on Thursday, climbing to approximately 14,736 points. This surge followed the US Federal Reserve’s decision to keep interest rates unchanged, which provided market stability. Growth was driven by pharmaceutical and consumer goods heavyweights, including Novartis, Nestlé, and Roche, as investors shifted capital toward defensive, crisis-resistant companies. Conversely, construction materials company Amrize saw shares drop by over 5% due to disappointing quarterly results and a lowered annual forecast. Despite geopolitical tensions in the Middle East and energy price concerns, the market demonstrated resilience.